COGT
Cogent Biosciences, Inc.
Stock
$31.02−0.57 (−1.80%)Close Oct 2, 2026
- Revenue, 2020
- $7.9M
- YoY, 2020
- −65.0%
Revenue
Revenue by fiscal year
| Period | Revenue | YoY |
|---|---|---|
| 2020 | $7.9M | −65.0% |
| 2019 | $22M | +131.1% |
| 2018 | $9.7M | +16.4% |
| 2017 | $8.4M | — |
Cogent Biosciences, Inc.
$31.02−0.57 (−1.80%)Close Oct 2, 2026
| Period | Revenue | YoY |
|---|---|---|
| 2020 | $7.9M | −65.0% |
| 2019 | $22M | +131.1% |
| 2018 | $9.7M | +16.4% |
| 2017 | $8.4M | — |